These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9622271)

  • 1. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
    Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
    Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
    J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
    Lappi DA; Maher PA; Martineau D; Baird A
    J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
    Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering.
    Xue L; Tassiopoulos AK; Woloson SK; Stanton DL; Ms CS; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 2001 Mar; 33(3):554-60. PubMed ID: 11241127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue.
    Shireman PK; Xue L; Maddox E; Burgess WH; Greisler HP
    J Vasc Surg; 2000 Feb; 31(2):382-90. PubMed ID: 10664506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.
    Chen C; Mattar SG; Hughes JD; Pierce GF; Cook JE; Ku DN; Hanson SR; Lumsden AB
    Circulation; 1996 Oct; 94(8):1989-95. PubMed ID: 8873678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of endothelial cell coculture on smooth muscle cell proliferation.
    Fillinger MF; O'Connor SE; Wagner RJ; Cronenwett JL
    J Vasc Surg; 1993 Jun; 17(6):1058-67; discussion 1067-8. PubMed ID: 8505784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models.
    Fillinger MF; Sampson LN; Cronenwett JL; Powell RJ; Wagner RJ
    J Surg Res; 1997 Feb; 67(2):169-78. PubMed ID: 9073564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor stimulates the competence phase of subcultured endothelial cells and the progression phase of primary cultured smooth muscle cells from rat aorta.
    Nagaura T; Okabe M; Kobayashi S; Kimura I; Kimura M
    Biol Pharm Bull; 1994 Sep; 17(9):1176-81. PubMed ID: 7841937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
    Ying W; Martineau D; Beitz J; Lappi DA; Baird A
    Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions.
    Kang SS; Gosselin C; Ren D; Greisler HP
    Surgery; 1995 Aug; 118(2):280-6; discussion 286-7. PubMed ID: 7638745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.
    Casscells W; Lappi DA; Olwin BB; Wai C; Siegman M; Speir EH; Sasse J; Baird A
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7159-63. PubMed ID: 1323129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
    Tetzke TA; Caton MC; Maher PA; Parandoosh Z
    Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local infusion of FGF-saporin reduces intimal hyperplasia.
    Mattar SG; Hanson SR; Pierce GF; Chen C; Hughes JD; Cook JE; Shen C; Noe BA; Suwyn CR; Scott JR; Lumsden AB
    J Surg Res; 1996 Feb; 60(2):339-44. PubMed ID: 8598665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
    Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
    Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
    Miller K; Wilder PJ; Rizzino A
    Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin glue containing fibroblast growth factor type 1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model.
    Zarge JI; Huang P; Husak V; Kim DU; Haudenschild CC; Nord RM; Greisler HP
    J Vasc Surg; 1997 May; 25(5):840-8; discussion 848-9. PubMed ID: 9152311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biointeractive polymers and tissue engineered blood vessels.
    Greisler HP; Gosselin C; Ren D; Kang SS; Kim DU
    Biomaterials; 1996 Feb; 17(3):329-36. PubMed ID: 8745330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.